People who hold medical marijuana cards may soon be able to put down the lighter and just squirt for relief.
A British pharmaceutical company is working its way toward FDA approval for the world's first prescription drug developed from raw marijuana instead of synthetic equivalents.
Some say the drug is a medical milestone that could mean a new era for the plant and the nation's uneasy relationship with it.
It's already been approved in Canada, New Zealand and eight European countries for relieving muscle spasms associated with multiple sclerosis.
The company is in advanced clinical trials to get its product approved in the United States as a treatment for severe cancer pain. It hopes to seek clearance from the U.S. Food and Drug Administration to put it on pharmacy shelves by the end of next year.
Do you think people who hold medical marijuana cards use the drug for its intended purpose? Tell us "Your Point of View" by voting in the poll below and leaving your comments.